Join

Compare · DFTX vs TLRY

DFTX vs TLRY

Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and Tilray Brands Inc. (TLRY): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both DFTX and TLRY operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
  • DFTX is the larger of the two at $2.57B, about 4.5x TLRY ($575.6M).
  • TLRY has been more active in the news (5 items in the past 4 weeks vs 3 for DFTX).
  • TLRY has more recent analyst coverage (14 ratings vs 4 for DFTX).
MetricDFTXTLRY
Company
Definium Therapeutics Inc.
Tilray Brands Inc.
Price
$22.55-4.29%
$5.01+1.42%
Market cap
$2.57B
$575.6M
1M return
-2.97%
-
1Y return
+190.41%
-
Sector
Health Care
Health Care
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NASDAQ
NASDAQ
IPO
2018
News (4w)
3
5
Recent ratings
4
14
TLRY

Tilray Brands Inc.

Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.

Latest DFTX

Latest TLRY